Literature DB >> 2369896

Functionally distinct insulin receptors generated by tissue-specific alternative splicing.

L Mosthaf1, K Grako, T J Dull, L Coussens, A Ullrich, D A McClain.   

Abstract

Cloning of the insulin receptor cDNA has earlier revealed the existence of two alternative forms of the receptor differing by the presence or absence of 12 amino acids near the C-terminus of the receptor alpha-subunit. This insert has been shown by others to be encoded by a discrete exon, and alternative splicing of this exon leads to tissue-specific expression of two receptor isoforms. We have studied the functional significance of the receptor isoforms and have confirmed that they are generated by alternative splicing. When cDNAs encoding the two forms of the insulin receptors are expressed in Rat 1 cells, the receptor lacking the insert (HIR-A) has a significantly higher affinity for insulin than the receptor with the insert (HIR-B). This difference in affinity is maintained when insulin binding activity is assayed in solution using detergent solubilized, partially purified receptors. These data, combined with the tissue specificity of HIR-A and HIR-B expression, suggest that alternative splicing may result in the modulation of insulin metabolism or responsiveness by different tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2369896      PMCID: PMC552265          DOI: 10.1002/j.1460-2075.1990.tb07416.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  13 in total

Review 1.  Growth factor receptor tyrosine kinases.

Authors:  Y Yarden; A Ullrich
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

2.  High-level expression of human insulin receptor cDNA in mouse NIH 3T3 cells.

Authors:  J Whittaker; A K Okamoto; R Thys; G I Bell; D F Steiner; C A Hofmann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling.

Authors:  Y Ebina; L Ellis; K Jarnagin; M Edery; L Graf; E Clauser; J H Ou; F Masiarz; Y W Kan; I D Goldfine
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

4.  A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis.

Authors:  D A McClain; H Maegawa; J Lee; T J Dull; A Ulrich; J M Olefsky
Journal:  J Biol Chem       Date:  1987-10-25       Impact factor: 5.157

5.  Localization of the insulin-binding site to the cysteine-rich region of the insulin receptor alpha-subunit.

Authors:  C C Yip; H Hsu; R G Patel; D M Hawley; B A Maddux; I D Goldfine
Journal:  Biochem Biophys Res Commun       Date:  1988-11-30       Impact factor: 3.575

6.  Alternative splicing of human insulin receptor messenger RNA.

Authors:  S Seino; G I Bell
Journal:  Biochem Biophys Res Commun       Date:  1989-02-28       Impact factor: 3.575

7.  Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin.

Authors:  C K Chou; T J Dull; D S Russell; R Gherzi; D Lebwohl; A Ullrich; O M Rosen
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

8.  Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity.

Authors:  Y Ebina; E Araki; M Taira; F Shimada; M Mori; C S Craik; K Siddle; S B Pierce; R A Roth; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

9.  Binding specificity and intramolecular signal transmission of uncleaved insulin proreceptor in transformed lymphocytes from a patient with extreme insulin resistance.

Authors:  T Sasaoka; Y Shigeta; Y Takata; M Sugibayashi; A Hisatomi; M Kobayashi
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

10.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose.

Authors:  L Ellis; E Clauser; D O Morgan; M Edery; R A Roth; W J Rutter
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

View more
  110 in total

Review 1.  Hepatic Insulin Clearance: Mechanism and Physiology.

Authors:  Sonia M Najjar; Germán Perdomo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

2.  Insulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of insulin receptor isoform A.

Authors:  Alaide Morcavallo; Marco Genua; Angela Palummo; Emilia Kletvikova; Jiri Jiracek; Andrzej M Brzozowski; Renato V Iozzo; Antonino Belfiore; Andrea Morrione
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

Review 3.  Signalling through the insulin receptor and the insulin-like growth factor-I receptor.

Authors:  E Van Obberghen
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

4.  Insulin receptor isoform switching in intestinal stem cells, progenitors, differentiated lineages and tumors: evidence that IR-B limits proliferation.

Authors:  Sarah F Andres; James G Simmons; Amanda T Mah; M Agostina Santoro; Laurianne Van Landeghem; P Kay Lund
Journal:  J Cell Sci       Date:  2013-10-14       Impact factor: 5.285

5.  Correlation of alpha-fetoprotein expression in normal hepatocytes during development with tyrosine phosphorylation and insulin receptor expression.

Authors:  L Khamzina; P Borgeat
Journal:  Mol Biol Cell       Date:  1998-05       Impact factor: 4.138

6.  Insulin receptor isotype expression correlates with risk of non-insulin-dependent diabetes.

Authors:  L Mosthaf; J Eriksson; H U Häring; L Groop; E Widen; A Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

Review 7.  Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.

Authors:  N Muge Kuyumcu-Martinez; Thomas A Cooper
Journal:  Prog Mol Subcell Biol       Date:  2006

Review 8.  The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes.

Authors:  Swapnil N Rajpathak; Marc J Gunter; Judith Wylie-Rosett; Gloria Y F Ho; Robert C Kaplan; Radhika Muzumdar; Thomas E Rohan; Howard D Strickler
Journal:  Diabetes Metab Res Rev       Date:  2009-01       Impact factor: 4.876

9.  Regulation of human insulin receptor RNA splicing in vivo.

Authors:  S Norgren; J Zierath; A Wedell; H Wallberg-Henriksson; H Luthman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

10.  PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer.

Authors:  A Belfiore; M Genua; R Malaguarnera
Journal:  PPAR Res       Date:  2009-07-07       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.